These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4447577)

  • 21. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial.
    Moutos D; Smith S; Zacur H
    Contraception; 1995 Aug; 52(2):105-9. PubMed ID: 8536446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Oral-cytological studies on the effect of combined contraceptive preparations as compared to menstruation and pregnancy].
    Zellner P; Klinger G
    Stomatol DDR; 1982 Oct; 32(10):673-7. PubMed ID: 6190274
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of exogenous steroids on gonadotrophin secretion.
    Johansson ED
    Clin Obstet Gynaecol; 1976 Dec; 3(3):579-90. PubMed ID: 1009733
    [No Abstract]   [Full Text] [Related]  

  • 24. The fallacy of the postpill amenorrhea syndrome.
    Archer DF; Thomas RL
    Clin Obstet Gynecol; 1981 Sep; 24(3):943-50. PubMed ID: 6793275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laboratory criteria for menopause in women using oral contraceptives.
    Creinin MD
    Fertil Steril; 1996 Jul; 66(1):101-4. PubMed ID: 8752618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of a cycle-regulating 2-phase preparation on peripheral and central cycle function].
    Schneider WH; Spona J; Matt K
    Ther Umsch; 1973 Jul; 30(7):516-23. PubMed ID: 4720331
    [No Abstract]   [Full Text] [Related]  

  • 28. [Continuous oral contraception using d-norgestrel (30 gamma). Analysis of changes in levels of gonadotropins and steroids].
    L'Hermite-Balériaux M; Hechtermans R; Jacob D
    J Gynecol Obstet Biol Reprod (Paris); 1973 Jun; 2(4):347-55. PubMed ID: 4807249
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of contraceptive steroids on hypothalamic-pituitary function.
    Mishell DR; Kletzky OA; Brenner PF; Roy S; Nicoloff J
    Am J Obstet Gynecol; 1977 May; 128(1):60-74. PubMed ID: 403765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
    Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormonal content of plasma and endometrium of women taking oral contraceptives.
    Porias H; Carranco-López A; Sojo-Aranda I; González-Martínez R; Cervantes C; Parra A; Cortés-Gallegos V
    Obstet Gynecol; 1978 Dec; 52(6):703-7. PubMed ID: 733138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New combined oral contraceptive with incremental progestogen dosage regimen.
    Brosens I; Van Assche A; Koninckx P; Heyns W; De Hertogh R
    Eur J Obstet Gynecol Reprod Biol; 1976; 6(6):315-8. PubMed ID: 1035172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.
    Rossmanith WG; Steffens D; Schramm G
    Contraception; 1997 Jul; 56(1):23-30. PubMed ID: 9306028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevation of serum prolactin during application of oral contraceptives.
    Dericks-Tan JS; Taubert HD
    Contraception; 1976 Jul; 14(1):1-8. PubMed ID: 975808
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antiepileptic drugs and oral contraceptives. Preliminary note].
    Meduri M; Bramanti B; Di Perri R; Volpe A; Oliva A; Baviera G
    Boll Soc Ital Biol Sper; 1978 Dec; 54(23):2462-7. PubMed ID: 756744
    [No Abstract]   [Full Text] [Related]  

  • 36. Serum gonadotropin and ovarian steroid levels in women during administration of a norethindrone-ethinylestradiol triphasic oral contraceptive.
    Ling WY; Johnston DW; Lea RH; Bent AE; Scott JZ; Toews MR
    Contraception; 1985 Oct; 32(4):367-75. PubMed ID: 3935373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the clinical performance of three triphasic oral contraceptives: a multicenter, randomized comparative trial.
    Schilling LH; Bolding OT; Chenault CB; Chong AP; Fleury F; Forrest K; Glick HI; Hasson HM; Heil CG; London RS
    Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1264-8. PubMed ID: 2655451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
    Carlström K; Lunell NO; Zador G
    Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The efficacy of gestoden (delta 15-d-norgestrel) as ovulation inhibitor (author's transl)].
    Schneider WH; Schmid R; Spona J
    Wien Klin Wochenschr; 1981 Oct; 93(19):601-4. PubMed ID: 6798765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of ovarian function by an oral contraceptive containing 30 micrograms ethinyl estradiol in combination with 2.00 mg dienogest.
    Spona J; Feichtinger W; Kindermann C; Moore C; Mellinger U; Walter F; Gräser T
    Contraception; 1997 Sep; 56(3):185-91. PubMed ID: 9347211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.